A 3-gene biomarker signature to predict response to taxane-based neoadjuvant chemotherapy in breast cancer.
Saved in:
| Title: | A 3-gene biomarker signature to predict response to taxane-based neoadjuvant chemotherapy in breast cancer. |
|---|---|
| Authors: | Kallarackal J; OakLabs GmbH, Hennigsdorf, Germany., Burger F; OakLabs GmbH, Hennigsdorf, Germany., Bianco S; OakLabs GmbH, Hennigsdorf, Germany., Romualdi A; OakLabs GmbH, Hennigsdorf, Germany., Schad M; OakLabs GmbH, Hennigsdorf, Germany. |
| Source: | PloS one [PLoS One] 2020 Mar 20; Vol. 15 (3), pp. e0230313. Date of Electronic Publication: 2020 Mar 20 (Print Publication: 2020). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1932-6203 |
|---|---|
| DOI: | 10.1371/journal.pone.0230313 |
